Atrás
54
Rango del Día
$23.23
$23.91
Rango de 52 Semanas
$9.03
$28.49
Volumen
480,424
Promedio 50D / 200D
$23.44
/
$19.06
Cierre Anterior
$24.02
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -21.6 | 0.3 |
| P/B | 6.5 | 2.9 |
| ROE % | -26.7 | 3.7 |
| Net Margin % | -76.6 | 3.8 |
| Rev Growth 5Y % | 41.2 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$34.67
+46.9%
Low: $26.00
High: $40.00
P/E Futuro
20.3
EPS Futuro
$1.19
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
290 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.92
$0.23 – $1.74
|
390 M | 2 |
| FY2029 |
$0.58
$0.15 – $1.10
|
300 M | 4 |
| FY2028 |
$0.03
-$0.26 – $0.34
|
180 M | 6 |
Puntos Clave
Revenue grew 41.17% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -34.53M
PEG of 0.73 suggests growth is underpriced
Capital efficient — spends only 1.44% of revenue on capex
Crecimiento
Revenue Growth (5Y)
41.17%
Revenue (1Y)38.87%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-26.72%
ROIC-24.20%
Net Margin-76.56%
Op. Margin-87.34%
Seguridad
Debt / Equity
0.07
Current Ratio5.52
Interest Coverage0.00
Valoración
P/E Ratio
-21.61
P/B Ratio6.53
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 38.87% | Revenue Growth (3Y) | 18.07% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 41.17% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 105.97M | Net Income (TTM) | -81.13M |
| ROE | -26.72% | ROA | -23.41% |
| Gross Margin | 89.81% | Operating Margin | -87.34% |
| Net Margin | -76.56% | Free Cash Flow (TTM) | -34.53M |
| ROIC | -24.20% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 5.52 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -21.61 | P/B Ratio | 6.53 |
| P/S Ratio | 16.55 | PEG Ratio | 0.73 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.75B | Enterprise Value | 1.73B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 105.97M | 76.30M | 76.01M | 412.48M | 26.68M |
| Net Income | -81.13M | -122.70M | -118.67M | 124.34M | -211.84M |
| EPS (Diluted) | -1.08 | -1.62 | -1.72 | 1.90 | -4.61 |
| Gross Profit | 95.17M | 76.30M | -66.98M | 412.48M | 26.68M |
| Operating Income | -92.55M | -137.11M | -138.05M | 130.53M | -215.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 346.53M | 463.09M | 580.88M | 648.73M | 389.13M |
| Total Liabilities | 78.03M | 124.32M | 116.07M | 155.77M | 140.04M |
| Shareholders' Equity | 268.50M | 338.77M | 464.81M | 492.96M | 249.09M |
| Total Debt | 18.27M | 18.51M | 26.72M | 28.11M | 32.33M |
| Cash & Equivalents | 41.16M | 66.10M | 157.56M | 400.91M | 201.87M |
| Current Assets | 233.44M | 300.45M | 412.93M | 544.71M | 288.22M |
| Current Liabilities | 42.32M | 88.29M | 55.76M | 95.63M | 71.85M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#49 of 146
Actividad Reciente
Entró
Full Throttle
Mar 24, 2026